PDCD1 and neoplasm: Programmed cell death 1 (PD-1) and PD-1 ligand (PD-L1) checkpoint blockade inhibited tumor growth in a CD4+ T-cell- and macrophage-dependent manner in a urinary bladder matrix-created immune microenvironment [11].